Scientific business developer at the Biomimetic systems for cell engineering Research Group
BD-EM // Deadline: 16/08/2026
Search Results for:
Enzyme Sensors and Chemical Probes
Our aim is to reveal disease mechanisms through the development of imaging tools and chemical probes, leading up to methods for translatable drug discovery. Understanding enzyme mechanisms We study the … Read more
Biomaterials for Neural Regeneration
The inability of the central nervous system (CNS) to regenerate has been attributed to several factors: First, the natural formation of cellular “bridges” essential for axonal regeneration does not occur … Read more
Research in Training at the Biomedical Signal Processing and Interpretation (BIOSPIN) Research Group
RT-ML // Deadline: 31/07/2026
Research Assistant at the Molecular and cellular Neurobiotechnology Research Group
RA-JR // Deadline: 26/07/2026
Postdoctoral researcher at the at the Biomimetic systems for cell engineering Group
PR-EM // Deadline: 26/07/2026
Predoctoral researcher at the Protein Phase Transitions in Health and Disease Research Group
PhD-BB // Deadline: 31/07/2026
IBEC-led consortium develops light-activated drugs that restore sight in blind mice
A consortium led by the Institute for Bioengineering of Catalonia (IBEC) developed this approach based on photopharmacology, a technique to reversibly control drug activity with light. The newly developed compounds, called prosthe6, mimic the function of photoreceptor cells, which degenerate in blinding diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP). These photoswitchable molecules show preliminary safety profiles and represent potential drug candidates for restoring vision in patients with degenerative retinal diseases, without the need for genetic manipulation or implanted devices.